Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients.
OBJECTIVE
We evaluated midodrine as oral treatment for pharmacologically induced priapism in spinal cord injured patients.


METHODS
From 2004 to 2007 we treated 354 spinal cord injured patients with intracavernous injection of prostaglandin E1 to induce erection. Prolonged erection or priapism occurred in 14 cases (1.3% of intracavernous injections). High blood pressure and bradycardia (autonomic dysreflexia) were noted in 2 tetraplegic cases. Except in 2 patients oral midodrine was used as the only therapeutic approach to this event because of its alpha stimulant properties.


RESULTS
All patients returned to the flaccid penile state within 30 to 45 minutes after midodrine administration. Oral midodrine was well tolerated with few side effects and without increasing the incidence of autonomic dysreflexia. At 6 months complete erection could be again induced by intracavernous injection in all treated patients.


CONCLUSIONS
Midodrine administered orally is a simple and efficient treatment for the priapism induced by intracavernous injection of prostaglandin E1. It could be the first line therapeutic approach before more aggressive procedures.
Soler
Jean-Marc
JM
Laboratoire d'Urodynamique et de Sexology, Centre Bouffard Vercelli, Cap Peyrefite, Cerbère, France.
Previnaire
Jean-Gabriel
JG
Mieusset
Roger
R
Plante
Pierre
P
D000284:Administration, Oral; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D008879:Midodrine / Q000008:administration & dosage*; D011317:Priapism / Q000139:chemically induced / Q000188:drug therapy*; D013119:Spinal Cord Injuries / Q000150:complications*; D055815:Young Adult
D000316:Adrenergic alpha-Agonists; D008879:Midodrine; D000527:Alprostadil